GERN Q1 2017 Earnings — Geron Corporation Revenue & Financial Results | Market Cap Arena

GERNGeron Corporation

$1B

Q1 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$537,000-28.3% YoY

Gross Profit

-$2M-381.6% margin

Operating Income

-$7M-1395.5% margin

Net Income

-$7M-1337.6% margin

EPS (Diluted)

$-0.05

QoQ Revenue Growth

+471.3%

Cash Flow

Operating Cash Flow

-$7M

Free Cash Flow

-$7M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$129M

Total Liabilities

$12M

Stockholders' Equity

$117M

Cash & Equivalents

$15M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$537,000	$749,000	-28.3%
Gross Profit	-$2M	-$3M	+36.4%
Operating Income	-$7M	-$9M	+17.4%
Net Income	-$7M	-$9M	+18.8%